| LA | |
|---|---|
| Post | - |
| Pre | - |
| M1 | M2 | M3 | M4 | M5 | M6 | M7 | M8 | M9 | M10 | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0 | - | - | - | - | 4.0 | 1798.0 | 401.0 | 2.0 | - | - | 2205 |
| 1 | - | - | - | - | - | 41.0 | 17.0 | - | - | - | 58 |
| LO1 | LO2 | LO3 | LO4 | LO5a | LO5b | LO6 | Total | |
|---|---|---|---|---|---|---|---|---|
| Post | - | - | - | - | - | - | - | - |
| Pre | - | - | - | - | - | - | - | - |
| AME | |
|---|---|
| 0 | 1 |
| 1 | 3 |
| LOP1 | LOP2 | LOP3 | LOP4 | Total | |
|---|---|---|---|---|---|
| Post | - | - | - | - | - |
| Pre | - | - | - | - | - |
| central brain | |
|---|---|
| 0 | 178 |
| 1 | 990 |
| Number of post synapses: | 2205 |
| Number of pre synapses: | 58 |
| Number of output connections: | 140 |
| Coverage factor: | 1.0 |
| Columnar completeness: | 0.34 |
| Area completeness: | 0.42 |
| Cell size (columns): | 307 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| Number of post synapses: | 0 |
| Number of pre synapses: | 0 |
| Number of output connections: | 0 |
| Coverage factor: | 0 |
| Columnar completeness: | 0 |
| Area completeness: | 0 |
| Cell size (columns): | 0 |
| instance | NT | total connections | connections /#MeVP25 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Dm2 (R) | ACh | 581 | 581.0 | 26.7% | 26.7% |
| 1 | Cm1 (R) | ACh | 218 | 218.0 | 10.0% | 36.8% |
| 2 | MeLo4 (R) | ACh | 185 | 185.0 | 8.5% | 45.3% |
| 3 | Cm3 (R) | GABA | 184 | 184.0 | 8.5% | 53.8% |
| 4 | Tm29 (R) | Glu | 174 | 174.0 | 8.0% | 61.8% |
| 5 | Cm9 (R) | Glu | 156 | 156.0 | 7.2% | 69.0% |
| 6 | Dm8a (R) | Glu | 82 | 82.0 | 3.8% | 72.7% |
| 7 | Mi10 (R) | ACh | 61 | 61.0 | 2.8% | 75.6% |
| 8 | MeVP7 (R) | ACh | 59 | 59.0 | 2.7% | 78.3% |
| 9 | Tm5b (R) | ACh | 53 | 53.0 | 2.4% | 80.7% |
| 10 | MeVC9 (L) | ACh | 38 | 38.0 | 1.7% | 82.5% |
| 11 | aMe17b (R) | GABA | 37 | 37.0 | 1.7% | 84.2% |
| 12 | TmY5a (R) | Glu | 35 | 35.0 | 1.6% | 85.8% |
| 13 | Cm17 (R) | GABA | 31 | 31.0 | 1.4% | 87.2% |
| 14 | MeLo3b (R) | ACh | 27 | 27.0 | 1.2% | 88.4% |
| 15 | MeVP8 (R) | ACh | 27 | 27.0 | 1.2% | 89.7% |
| 16 | Cm11d (R) | ACh | 18 | 18.0 | 0.8% | 90.5% |
| 17 | Cm31b (R) | GABA | 15 | 15.0 | 0.7% | 91.2% |
| 18 | MeVP52 (R) | ACh | 13 | 13.0 | 0.6% | 91.8% |
| 19 | MeVP9 (R) | ACh | 12 | 12.0 | 0.6% | 92.4% |
| 20 | MeTu1 (R) | ACh | 11 | 11.0 | 0.5% | 92.9% |
| 21 | Mi15 (R) | ACh | 11 | 11.0 | 0.5% | 93.4% |
| 22 | MeVP33 (R) | ACh | 9 | 9.0 | 0.4% | 93.8% |
| 23 | Tm40 (R) | ACh | 8 | 8.0 | 0.4% | 94.2% |
| 24 | MeVP2 (R) | ACh | 6 | 6.0 | 0.3% | 94.4% |
| 25 | MeVPMe7 (L) | Glu | 6 | 6.0 | 0.3% | 94.7% |
| 26 | Cm2 (R) | ACh | 5 | 5.0 | 0.2% | 94.9% |
| 27 | MeVP21 (R) | ACh | 5 | 5.0 | 0.2% | 95.2% |
| 28 | aMe12 (R) | ACh | 4 | 4.0 | 0.2% | 95.3% |
| 29 | aMe17e (R) | Glu | 4 | 4.0 | 0.2% | 95.5% |
| 30 | Cm34 (R) | Glu | 4 | 4.0 | 0.2% | 95.7% |
| 31 | MeTu3c (R) | ACh | 4 | 4.0 | 0.2% | 95.9% |
| 32 | MeVPLo2 (R) | ACh | 4 | 4.0 | 0.2% | 96.1% |
| 33 | Cm10 (R) | GABA | 3 | 3.0 | 0.1% | 96.2% |
| 34 | Cm11c (R) | ACh | 3 | 3.0 | 0.1% | 96.4% |
| 35 | Cm21 (R) | GABA | 3 | 3.0 | 0.1% | 96.5% |
| 36 | Cm8 (R) | GABA | 3 | 3.0 | 0.1% | 96.6% |
| 37 | Cm_unclear (R) | ACh | 3 | 3.0 | 0.1% | 96.8% |
| 38 | Dm8b (R) | Glu | 3 | 3.0 | 0.1% | 96.9% |
| 39 | ME_unclear (R) | ACh | 3 | 3.0 | 0.1% | 97.1% |
| 40 | MeVPaMe2 (L) | Glu | 3 | 3.0 | 0.1% | 97.2% |
| 41 | Tm26 (R) | ACh | 3 | 3.0 | 0.1% | 97.3% |
| 42 | Tm5a (R) | ACh | 3 | 3.0 | 0.1% | 97.5% |
| 43 | Tm5c (R) | Glu | 3 | 3.0 | 0.1% | 97.6% |
| 44 | Cm11b (R) | ACh | 2 | 2.0 | 0.1% | 97.7% |
| 45 | Cm12 (R) | GABA | 2 | 2.0 | 0.1% | 97.8% |
| 46 | Cm24 (R) | Glu | 2 | 2.0 | 0.1% | 97.9% |
| 47 | Cm31a (R) | GABA | 2 | 2.0 | 0.1% | 98.0% |
| 48 | Cm5 (R) | GABA | 2 | 2.0 | 0.1% | 98.1% |
| 49 | Dm9 (R) | Glu | 2 | 2.0 | 0.1% | 98.2% |
| 50 | MeTu4f (R) | ACh | 2 | 2.0 | 0.1% | 98.3% |
| 51 | MeVP29 (R) | ACh | 2 | 2.0 | 0.1% | 98.3% |
| 52 | MeVP43 (R) | ACh | 2 | 2.0 | 0.1% | 98.4% |
| 53 | MeVPMe7 (R) | Glu | 2 | 2.0 | 0.1% | 98.5% |
| 54 | OA-AL2i4 (R) | OA | 2 | 2.0 | 0.1% | 98.6% |
| 55 | TmY17 (R) | ACh | 2 | 2.0 | 0.1% | 98.7% |
| 56 | 5-HTPMPV03 (R) | 5HT | 1 | 1.0 | 0.0% | 98.8% |
| 57 | aMe30 (R) | Glu | 1 | 1.0 | 0.0% | 98.8% |
| 58 | aMe4 (R) | ACh | 1 | 1.0 | 0.0% | 98.8% |
| 59 | Cm11a (R) | ACh | 1 | 1.0 | 0.0% | 98.9% |
| 60 | Cm15 (R) | GABA | 1 | 1.0 | 0.0% | 98.9% |
| 61 | Cm19 (R) | GABA | 1 | 1.0 | 0.0% | 99.0% |
| 62 | Cm29 (R) | GABA | 1 | 1.0 | 0.0% | 99.0% |
| 63 | Cm30 (R) | GABA | 1 | 1.0 | 0.0% | 99.1% |
| 64 | Cm6 (R) | GABA | 1 | 1.0 | 0.0% | 99.1% |
| 65 | MeTu3b (R) | ACh | 1 | 1.0 | 0.0% | 99.2% |
| 66 | MeVC2 (L) | ACh | 1 | 1.0 | 0.0% | 99.2% |
| 67 | MeVC20 (R) | Glu | 1 | 1.0 | 0.0% | 99.3% |
| 68 | MeVC22 (R) | Glu | 1 | 1.0 | 0.0% | 99.3% |
| 69 | MeVP1 (R) | ACh | 1 | 1.0 | 0.0% | 99.4% |
| 70 | MeVP30 (R) | ACh | 1 | 1.0 | 0.0% | 99.4% |
| 71 | MeVP41 (R) | ACh | 1 | 1.0 | 0.0% | 99.4% |
| 72 | MeVP42 (R) | ACh | 1 | 1.0 | 0.0% | 99.5% |
| 73 | MeVPMe13 (R) | ACh | 1 | 1.0 | 0.0% | 99.5% |
| 74 | MeVPMe3 (L) | Glu | 1 | 1.0 | 0.0% | 99.6% |
| 75 | MeVPMe4 (L) | Glu | 1 | 1.0 | 0.0% | 99.6% |
| 76 | MeVPMe6 (L) | Glu | 1 | 1.0 | 0.0% | 99.7% |
| 77 | MeVPMe9 (R) | Glu | 1 | 1.0 | 0.0% | 99.7% |
| 78 | Mi18 (R) | GABA | 1 | 1.0 | 0.0% | 99.8% |
| 79 | OLVC2 (L) | GABA | 1 | 1.0 | 0.0% | 99.8% |
| 80 | Pm9 (R) | GABA | 1 | 1.0 | 0.0% | 99.9% |
| 81 | Tm30 (R) | GABA | 1 | 1.0 | 0.0% | 99.9% |
| 82 | Tm31 (R) | Glu | 1 | 1.0 | 0.0% | 100.0% |
| 83 | Tm36 (R) | ACh | 1 | 1.0 | 0.0% | 100.0% |
| instance | NT | total connections | connections /#MeVP25 (R) | % | % cumu. | |
|---|---|---|---|---|---|---|
| 0 | Tm5b (R) | ACh | 32 | 32.0 | 21.5% | 21.5% |
| 1 | Cm11d (R) | ACh | 10 | 10.0 | 6.7% | 28.2% |
| 2 | Cm11a (R) | ACh | 8 | 8.0 | 5.4% | 33.6% |
| 3 | Cm11b (R) | ACh | 8 | 8.0 | 5.4% | 38.9% |
| 4 | Cm33 (R) | GABA | 8 | 8.0 | 5.4% | 44.3% |
| 5 | Cm9 (R) | Glu | 7 | 7.0 | 4.7% | 49.0% |
| 6 | Cm15 (R) | GABA | 5 | 5.0 | 3.4% | 52.3% |
| 7 | Cm34 (R) | Glu | 5 | 5.0 | 3.4% | 55.7% |
| 8 | Tm5c (R) | Glu | 5 | 5.0 | 3.4% | 59.1% |
| 9 | aMe15 (R) | unclear | 4 | 4.0 | 2.7% | 61.7% |
| 10 | Cm11c (R) | ACh | 4 | 4.0 | 2.7% | 64.4% |
| 11 | Tm5a (R) | ACh | 4 | 4.0 | 2.7% | 67.1% |
| 12 | MeVP10 (R) | ACh | 3 | 3.0 | 2.0% | 69.1% |
| 13 | MeVP21 (R) | ACh | 3 | 3.0 | 2.0% | 71.1% |
| 14 | MeVPMe13 (R) | ACh | 3 | 3.0 | 2.0% | 73.2% |
| 15 | Tm12 (R) | ACh | 3 | 3.0 | 2.0% | 75.2% |
| 16 | Tm29 (R) | Glu | 3 | 3.0 | 2.0% | 77.2% |
| 17 | aMe10 (R) | ACh | 2 | 2.0 | 1.3% | 78.5% |
| 18 | Cm26 (R) | Glu | 2 | 2.0 | 1.3% | 79.9% |
| 19 | Tm26 (R) | ACh | 2 | 2.0 | 1.3% | 81.2% |
| 20 | TmY5a (R) | Glu | 2 | 2.0 | 1.3% | 82.6% |
| 21 | aMe12 (R) | ACh | 1 | 1.0 | 0.7% | 83.2% |
| 22 | aMe4 (R) | ACh | 1 | 1.0 | 0.7% | 83.9% |
| 23 | aMe5 (R) | ACh | 1 | 1.0 | 0.7% | 84.6% |
| 24 | Cm1 (R) | ACh | 1 | 1.0 | 0.7% | 85.2% |
| 25 | Cm19 (R) | GABA | 1 | 1.0 | 0.7% | 85.9% |
| 26 | Cm30 (R) | GABA | 1 | 1.0 | 0.7% | 86.6% |
| 27 | Cm32 (R) | GABA | 1 | 1.0 | 0.7% | 87.2% |
| 28 | Cm35 (R) | GABA | 1 | 1.0 | 0.7% | 87.9% |
| 29 | Cm5 (R) | GABA | 1 | 1.0 | 0.7% | 88.6% |
| 30 | Dm2 (R) | ACh | 1 | 1.0 | 0.7% | 89.3% |
| 31 | Dm8a (R) | Glu | 1 | 1.0 | 0.7% | 89.9% |
| 32 | l-LNv (R) | unclear | 1 | 1.0 | 0.7% | 90.6% |
| 33 | MeLo4 (R) | ACh | 1 | 1.0 | 0.7% | 91.3% |
| 34 | MeVP1 (R) | ACh | 1 | 1.0 | 0.7% | 91.9% |
| 35 | MeVP18 (R) | unclear | 1 | 1.0 | 0.7% | 92.6% |
| 36 | MeVP41 (R) | ACh | 1 | 1.0 | 0.7% | 93.3% |
| 37 | MeVP42 (R) | ACh | 1 | 1.0 | 0.7% | 94.0% |
| 38 | MeVP49 (R) | unclear | 1 | 1.0 | 0.7% | 94.6% |
| 39 | MeVP50 (R) | unclear | 1 | 1.0 | 0.7% | 95.3% |
| 40 | MeVP6_unclear (R) | Glu | 1 | 1.0 | 0.7% | 96.0% |
| 41 | Mi15 (R) | ACh | 1 | 1.0 | 0.7% | 96.6% |
| 42 | OA-AL2i4 (R) | OA | 1 | 1.0 | 0.7% | 97.3% |
| 43 | s-LNv (R) | unclear | 1 | 1.0 | 0.7% | 98.0% |
| 44 | Tm30 (R) | GABA | 1 | 1.0 | 0.7% | 98.7% |
| 45 | Tm39 (R) | ACh | 1 | 1.0 | 0.7% | 99.3% |
| 46 | TmY9b (R) | ACh | 1 | 1.0 | 0.7% | 100.0% |